Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation

Dave Singh, Leonardo M. Fabbri, Massimo Corradi, George Georges, Alessandro Guasconi, Stefano Vezzoli, Stefano Petruzzelli, Alberto Papi
European Respiratory Journal 2019 53: 1900235; DOI: 10.1183/13993003.00235-2019
Dave Singh
1Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dsingh@meu.org.uk
Leonardo M. Fabbri
2Section of Cardiorespiratory and Internal Medicine, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
3COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Leonardo M. Fabbri
Massimo Corradi
4Dept Medicine and Surgery, University of Parma, Parma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Georges
5Global Clinical Development, Chiesi USA, Inc., Cary, NC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessandro Guasconi
6Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Vezzoli
6Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Petruzzelli
6Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Papi
2Section of Cardiorespiratory and Internal Medicine, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alberto Papi
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 53 no. 5
DOI 
https://doi.org/10.1183/13993003.00235-2019
PubMed 
30792343

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Received January 24, 2019
  • Accepted February 12, 2019
  • Published online May 18, 2019.

Article Versions

  • previous version (February 20, 2019 - 23:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©ERS 2019

Author Information

  1. Dave Singh1⇑,
  2. Leonardo M. Fabbri2,3,
  3. Massimo Corradi4,
  4. George Georges5,
  5. Alessandro Guasconi6,
  6. Stefano Vezzoli6,
  7. Stefano Petruzzelli6 and
  8. Alberto Papi2
  1. 1Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, UK
  2. 2Section of Cardiorespiratory and Internal Medicine, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy
  3. 3COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden
  4. 4Dept Medicine and Surgery, University of Parma, Parma, Italy
  5. 5Global Clinical Development, Chiesi USA, Inc., Cary, NC, USA
  6. 6Global Clinical Development, Chiesi Farmaceutici SpA, Parma, Italy
  1. Dave Singh, University of Manchester, Medicines Evaluation Unit, Manchester, M23 9QZ, UK. E-mail: dsingh{at}meu.org.uk
View Full Text

Funding

  • Chiesi Farmaceutici

Article usage

Article usage: February 2019 to January 2023

AbstractFullPdf
Feb 2019194415212
Mar 2019151311133
Apr 20196219260
May 20193257387
Jun 201911601120
Jul 20191041079
Aug 20191441852
Sep 20191216276
Oct 2019412962
Nov 2019510860
Dec 201947122
Jan 202039249
Feb 202078630
Mar 202057626
Apr 2020310529
May 2020316179
Jun 202058936
Jul 202029336
Aug 202029526
Sep 202019034
Oct 202097929
Nov 2020212349
Dec 202068121
Jan 202139763
Feb 202107033
Mar 2021710559
Apr 202156126
May 202117232
Jun 202119136
Jul 202136242
Aug 202137324
Sep 202158140
Oct 202126934
Nov 202196448
Dec 202105728
Jan 202214024
Feb 202204514
Mar 202215219
Apr 202235426
May 202203626
Jun 202215129
Jul 202205126
Aug 202226938
Sep 202203832
Oct 202235726
Nov 202215837
Dec 20221409
Jan 202313810

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 53 Issue 5 Table of Contents
European Respiratory Journal: 53 (5)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
Dave Singh, Leonardo M. Fabbri, Massimo Corradi, George Georges, Alessandro Guasconi, Stefano Vezzoli, Stefano Petruzzelli, Alberto Papi
European Respiratory Journal May 2019, 53 (5) 1900235; DOI: 10.1183/13993003.00235-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation
Dave Singh, Leonardo M. Fabbri, Massimo Corradi, George Georges, Alessandro Guasconi, Stefano Vezzoli, Stefano Petruzzelli, Alberto Papi
European Respiratory Journal May 2019, 53 (5) 1900235; DOI: 10.1183/13993003.00235-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Airway immune responses to COVID-19 vaccination in COPD patients
  • Wider access to rifapentine-based regimens is needed for TB care globally
  • Screening for PVOD in heterozygous EIF2AK4 variant carriers
Show more Agora

Research letters

  • Impact of depression and anxiety on exacerbation risk in bronchiectasis
  • Respiratory management of drowning-associated ARF
  • Mitochondrial DNA as biomarker of survival in RA-ILD
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society